Skip to content
2000
Volume 10, Issue 7
  • ISSN: 1573-4064
  • E-ISSN: 1875-6638

Abstract

Low-grade chronic inflammation is now being held as an important process in the development of atherosclerosis, with new links between dyslipidemia and inflammation being constantly found. While most studies aim to discover inflammatory pathways leading from dyslipidemia to atherogenesis, there is evidence that inflammation can also act in reverse, altering lipid metabolism in unfavorable ways, possibly creating a vicious cycle of inflammationdyslipidemia- inflammation. This is highly relevant for the search of novel therapeutic targets. In this review, after a brief account of the inflammatory mechanisms leading from dyslipidemia to atherogenesis, we focus on what is currently known about the ways inflammation can impair lipid metabolism and whether anti-inflammatory therapies could have a role in dyslipidemia management.

Loading

Article metrics loading...

/content/journals/mc/10.2174/1573406410666140318101936
2014-11-01
2025-06-01
Loading full text...

Full text loading...

/content/journals/mc/10.2174/1573406410666140318101936
Loading

  • Article Type:
    Research Article
Keyword(s): Atherosclerosis; CAD; cholesterol; dyslipidemia; inflammation; lipids
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test